BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32496217)

  • 1. High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor.
    Landi G; Linciano P; Tassone G; Costi MP; Mangani S; Pozzi C
    Acta Crystallogr D Struct Biol; 2020 Jun; 76(Pt 6):558-564. PubMed ID: 32496217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Insights into the Development of Cycloguanil Derivatives as
    Landi G; Linciano P; Borsari C; Bertolacini CP; Moraes CB; Cordeiro-da-Silva A; Gul S; Witt G; Kuzikov M; Costi MP; Pozzi C; Mangani S
    ACS Infect Dis; 2019 Jul; 5(7):1105-1114. PubMed ID: 31012301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Potential Inhibitors of Pteridine Reductase 1 in
    Kimuda MP; Laming D; Hoppe HC; Tastan Bishop Ö
    Molecules; 2019 Jan; 24(1):. PubMed ID: 30609681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate.
    Dawson A; Gibellini F; Sienkiewicz N; Tulloch LB; Fyfe PK; McLuskey K; Fairlamb AH; Hunter WN
    Mol Microbiol; 2006 Sep; 61(6):1457-68. PubMed ID: 16968221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sesquiterpene Lactones with Dual Inhibitory Activity against the
    Possart K; Herrmann FC; Jose J; Costi MP; Schmidt TJ
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could chroman-4-one derivative be a better inhibitor of PTR1? - Reason for the identified disparity in its inhibitory potency in Trypanosoma brucei and Leishmania major.
    Omolabi KF; Iwuchukwu EA; Odeniran PO; Soliman MES
    Comput Biol Chem; 2021 Feb; 90():107412. PubMed ID: 33199197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of
    Tassone G; Landi G; Linciano P; Francesconi V; Tonelli M; Tagliazucchi L; Costi MP; Mangani S; Pozzi C
    Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34209148
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
    Tulloch LB; Martini VP; Iulek J; Huggan JK; Lee JH; Gibson CL; Smith TK; Suckling CJ; Hunter WN
    J Med Chem; 2010 Jan; 53(1):221-9. PubMed ID: 19916554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
    Cavazzuti A; Paglietti G; Hunter WN; Gamarro F; Piras S; Loriga M; Allecca S; Corona P; McLuskey K; Tulloch L; Gibellini F; Ferrari S; Costi MP
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1448-53. PubMed ID: 18245389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.
    Linciano P; Pozzi C; Iacono LD; di Pisa F; Landi G; Bonucci A; Gul S; Kuzikov M; Ellinger B; Witt G; Santarem N; Baptista C; Franco C; Moraes CB; Müller W; Wittig U; Luciani R; Sesenna A; Quotadamo A; Ferrari S; Pöhner I; Cordeiro-da-Silva A; Mangani S; Costantino L; Costi MP
    J Med Chem; 2019 Apr; 62(8):3989-4012. PubMed ID: 30908048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design and synthesis of antiparasitic pyrrolopyrimidines targeting pteridine reductase 1.
    Khalaf AI; Huggan JK; Suckling CJ; Gibson CL; Stewart K; Giordani F; Barrett MP; Wong PE; Barrack KL; Hunter WN
    J Med Chem; 2014 Aug; 57(15):6479-94. PubMed ID: 25007262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico and In Vitro Search for Dual Inhibitors of the
    Possart K; Herrmann FC; Jose J; Schmidt TJ
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity.
    Di Pisa F; Landi G; Dello Iacono L; Pozzi C; Borsari C; Ferrari S; Santucci M; Santarem N; Cordeiro-da-Silva A; Moraes CB; Alcantara LM; Fontana V; Freitas-Junior LH; Gul S; Kuzikov M; Behrens B; Pöhner I; Wade RC; Costi MP; Mangani S
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28282886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the
    Shamshad H; Hafiz A; Althagafi II; Saeed M; Mirza AZ
    Curr Comput Aided Drug Des; 2020; 16(5):583-598. PubMed ID: 31453790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign.
    Linciano P; Cullia G; Borsari C; Santucci M; Ferrari S; Witt G; Gul S; Kuzikov M; Ellinger B; Santarém N; Cordeiro da Silva A; Conti P; Bolognesi ML; Roberti M; Prati F; Bartoccini F; Retini M; Piersanti G; Cavalli A; Goldoni L; Bertozzi SM; Bertozzi F; Brambilla E; Rizzo V; Piomelli D; Pinto A; Bandiera T; Costi MP
    Eur J Med Chem; 2020 Mar; 189():112047. PubMed ID: 31982652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore Mapping, In Silico Screening and Molecular Docking to Identify Selective Trypanosoma brucei Pteridine Reductase Inhibitors.
    Dube D; Sharma S; Singh TP; Kaur P
    Mol Inform; 2014 Feb; 33(2):124-34. PubMed ID: 27485569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Innovative Folate Inhibitors Leveraging the Amino Dihydrotriazine Motif from Cycloguanil for Their Potential as Anti-
    Francesconi V; Rizzo M; Pozzi C; Tagliazucchi L; Konchie Simo CU; Saporito G; Landi G; Mangani S; Carbone A; Schenone S; Santarém N; Tavares J; Cordeiro-da-Silva A; Costi MP; Tonelli M
    ACS Infect Dis; 2024 Jul; ():. PubMed ID: 38953453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a simple quantum chemical approach to ligand fragment scoring for Trypanosoma brucei pteridine reductase 1 inhibition.
    Jedwabny W; Panecka-Hofman J; Dyguda-Kazimierowicz E; Wade RC; Sokalski WA
    J Comput Aided Mol Des; 2017 Aug; 31(8):715-728. PubMed ID: 28688090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting a Large Active Site: Structure-Based Design of Nanomolar Inhibitors of Trypanosoma brucei Trypanothione Reductase.
    De Gasparo R; Halgas O; Harangozo D; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
    Chemistry; 2019 Sep; 25(49):11416-11421. PubMed ID: 31407832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel inhibitors of Trypanosoma brucei pteridine reductase 1.
    Spinks D; Ong HB; Mpamhanga CP; Shanks EJ; Robinson DA; Collie IT; Read KD; Frearson JA; Wyatt PG; Brenk R; Fairlamb AH; Gilbert IH
    ChemMedChem; 2011 Feb; 6(2):302-8. PubMed ID: 21275054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.